Alvogen’s Lotus Picks Up Darbepoetin Alfa Rights In Asia

Biosimilar Agreement Covers Taiwan And Key Asian Markets

 
• By Dean Rudge
Asia - Pacific
The combined size of Lotus’ markets of interest is roughly US$30m • Source: Shutterstock

More from Deals

More from Business